Sanjeev Sethi

2001–2025 年に発表

156
論文数
25,180
被引用数
87
h 指数
148
i10 指数

被引用数

Sanjeev Sethi の年別被引用数1994 年: 被引用 6 件2002 年: 被引用 4 件2003 年: 被引用 10 件2004 年: 被引用 8 件2005 年: 被引用 12 件2006 年: 被引用 16 件2007 年: 被引用 14 件2008 年: 被引用 53 件2009 年: 被引用 36 件2010 年: 被引用 78 件2011 年: 被引用 79 件2012 年: 被引用 132 件2013 年: 被引用 150 件2014 年: 被引用 72 件2015 年: 被引用 144 件2016 年: 被引用 160 件2017 年: 被引用 87 件2018 年: 被引用 218 件2019 年: 被引用 513 件2020 年: 被引用 639 件2021 年: 被引用 755 件2022 年: 被引用 762 件2023 年: 被引用 792 件2024 年: 被引用 1,262 件2025 年: 被引用 581 件2026 年: 被引用 7 件1995〜2001 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,430 件、この内訳の 23.4%中国: 引用元論文 697 件、この内訳の 11.4%イギリス: 引用元論文 395 件、この内訳の 6.5%イタリア: 引用元論文 350 件、この内訳の 5.7%フランス: 引用元論文 334 件、この内訳の 5.5%ドイツ: 引用元論文 314 件、この内訳の 5.1%カナダ: 引用元論文 240 件、この内訳の 3.9%スペイン: 引用元論文 225 件、この内訳の 3.7%日本: 引用元論文 192 件、この内訳の 3.1%オランダ: 引用元論文 191 件、この内訳の 3.1%オーストラリア: 引用元論文 137 件、この内訳の 2.3%スイス: 引用元論文 108 件、この内訳の 1.8%
0%23.4%その他 24.5%

分野

  • Medicine69%
  • Immunology and Microbiology15.2%
  • Biochemistry, Genetics and Molecular Biology11.4%
  • Computer Science1.4%
  • Nursing1.2%
  • Engineering0.5%
  • その他1.3%

トピック

  • Renal Diseases and Glomerulopathies15.9%
  • Complement system in diseases6.1%
  • Vasculitis and related conditions5.4%
  • Chronic Kidney Disease and Diabetes4.8%
  • Systemic Lupus Erythematosus Research3.9%
  • Amyloidosis: Diagnosis, Treatment, Outcomes3.7%
  • その他60.2%

共著者

全論文

検索で開く
  1. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Kidney International 2021 被引用: 2,416

  2. Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices

    著者: , , , , , , , , , , , , , , , , , - Kidney International 2018 被引用: 1,000

  3. Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Howell, Marcello Tonelli, Michael Cheung, Amy Earley, Jürgen Floege - Kidney International 2021 被引用: 791

  4. Membranous nephropathy

    著者: , , , , , , , , , - Nature Reviews Disease Primers 2021 被引用: 460

  5. Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jay Radhakrishnan, Heather N. Reich, Samir V. Parikh, Debbie S. Gipson, Dominic K. Lee, Bruno R. da Costa, Peter Jüni, Daniel Cattran - New England Journal of Medicine 2019 被引用: 600

  6. A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction

    著者: , , , , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2016 被引用: 288

  7. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel P. Gale, Hermann Haller, Sally Johnson, Mihály Józsi, Diana Karpman, Lynne D. Lanning, Moglie Le Quintrec, Christoph Licht, Chantal Loirat, Francisco Monfort, B. Paul Morgan, Laure-Hélène Noël, Michelle M. O’Shaughnessy, Marion Rabant, Éric Rondeau, Piero Ruggenenti, Neil Sheerin, Jenna L.H. Smith, Fabrizio Spoleti, Joshua M. Thurman, Nicole C. A. J. van de Kar, Marina Vivarelli, Peter F. Zipfel - Kidney International 2016 被引用: 695

  8. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy

    著者: , , , , , , , , , , - Kidney International 2019 被引用: 353

  9. C3 glomerulopathy — understanding a rare complement-driven renal disease

    著者: , , , , , , , , , , , , , , , , , - Nature Reviews Nephrology 2019 被引用: 396

  10. C3 glomerulopathy: consensus report

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wen-Chao Song, Paul P. Tamburini, Joshua M. Thurman, Michael Zavros, H. Terence Cook - Kidney International 2013 被引用: 641

  11. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nina Görlich, Mark Haas, Alister Humphreys, Vivekanand Jha, Arenn Jauhal, David Kavanagh, Andreas Kronbichler, Richard Lafayette, Lynne D. Lanning, Mathieu Lemaire, Moglie Le Quintrec, Christoph Licht, Adrian Liew, Steve McAdoo, Nicholas Medjeral‐Thomas, Pier Luigi Meroni, Johann Morelle, Carla Nester, Manuel Praga, Raja Ramachandran, Heather N. Reich, Giuseppe Remuzzi, Santiago Rodrı́guez de Córdoba, Gary Robinson, Pierre Ronco, Peter Rossing, David J. Salant, Sanjeev Sethi, Marianne Silkjaer, Wen‐Chao Song, Fabrizio Spoleti, Ronald P. Taylor, Nicole C. A. J. van de Kar, Cees van Kooten, Len Woodward, Yuzhou Zhang, Peter F. Zipfel, Marco Zuccato - Kidney International 2024 被引用: 125

  12. Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonello Pani, Manuel Praga, Giuseppe Remuzzi, Helmut G. Rennke, Piero Ruggenenti, Dario Roccatello, María José Soler, Ulrich Specks, Rolf A.K. Stahl, Raman Deep Singh, Jason D. Theis, Jorge A. Velosa, Jack F.M. Wetzels, Christopher G. Winearls, Federico Yandián, Ladan Zand, Pierre Ronco, Fernando C. Fervenza - Kidney International 2023 被引用: 113

  13. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ashutosh Wechalekar, Brendan M. Weiss, Samih H. Nasr - Nature Reviews Nephrology 2018 被引用: 534

  14. Exostosin 1/Exostosin 2–Associated Membranous Nephropathy

    著者: , , , , , , , , , - Journal of the American Society of Nephrology 2019 被引用: 304

  15. Protocadherin 7–Associated Membranous Nephropathy

    著者: , , , , , , , , , , , - Journal of the American Society of Nephrology 2021 被引用: 161

  16. New ‘Antigens’ in Membranous Nephropathy

    著者: - Journal of the American Society of Nephrology 2020 被引用: 226

  17. A proposal for standardized grading of chronic changes in native kidney biopsy specimens

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Kidney International 2017 被引用: 276

  18. Semaphorin 3B–associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients

    著者: , , , , , , , , , , , , , - Kidney International 2020 被引用: 206

  19. Hematopoietic Stem Cell Transplant-Membranous Nephropathy Is Associated with Protocadherin FAT1

    著者: , , , , , , , , , , , , - Journal of the American Society of Nephrology 2022 被引用: 108

  20. Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , An S. De Vriese, Jai Radhakrishnan, Lorraine C. Racusen, Pierre Ronco, Fernando C. Fervenza - Journal of the American Society of Nephrology 2015 被引用: 309

  21. A Proposal for a Serology-Based Approach to Membranous Nephropathy

    著者: , , , , - Journal of the American Society of Nephrology 2016 被引用: 373

  22. Biopsy-Proven Acute Interstitial Nephritis, 1993-2011: A Case Series

    著者: , , , , , , - American Journal of Kidney Diseases 2014 被引用: 344

  23. Membranoproliferative Glomerulonephritis — A New Look at an Old Entity

    著者: , - New England Journal of Medicine 2012 被引用: 556

  24. Clinical Findings, Pathology, and Outcomes of C3GN after Kidney Transplantation

    著者: , , , , , , , - Journal of the American Society of Nephrology 2013 被引用: 187